Understanding the TB Market

To optimize the development and introduction of new TB products, it’s important to thoroughly understand the market. TB Alliance has investigated key characteristics of health systems to ensure products in development are in line with local needs and realities and is tackling some of the major questions and issues that could help ensure new regimens have their maximum impact on the pandemic.

TB Market Research

SLASH-TB

With this flexible model, developed by TB Alliance and Swiss Tropical and Public Health Institute, users can quickly generate a customized cost effectiveness analysis for implementing six-month drug-resistant TB treatments.

Learn More

Determining the Pediatric TB Burden

A major historical challenge in tackling childhood TB has been understanding the scope of the problem.

Learn More

The Global TB Market

Pathway to Patients: Charting the Dynamics of the Global TB Drug Market, was the first comprehensive analysis of how today's TB drugs reach patients on a global scale.

Learn More

Value Propositions of New Regimens

TB Alliance sought opinions on attributes that key decision-makers want in new regimens, including safety, efficacy, drug delivery, side effect profiles, and cost.

Learn More

Understanding Regimen Change

TB Alliance investigated health systems to understand the regimen change process, in order to accelerate and maximize the uptake of new products.

Learn More

Defining the Role of the Private Sector in Treatment

TB treatment is widely understood to be a public sector responsibility. However, our research found that in some countries the volume of TB drugs sold in the private sector is equal to or greater than the volume sold in the public sector.

Learn More